In fact, considering the commonalities observed between cancer cells and synthetic VSMCs (increased MMP expression, cytoskeletal instability, etc.), the ability of MALAT1 depletion to induce a differentiated phenotype may prove a generalized strategy to improve cellular performance in multiple conditions associated with cellular dedifferentiation. Here, MALAT1 is linked to cancer.